prikaz prve stranice dokumenta Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
  Preuzmi
PDF 1.37 MB
Znanstveni rad - Izvorni znanstveni rad
Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
Neurological Sciences, 39 (2018), 12; 2079-2084. https://doi.org/10.1007/s10072-018-3542-8
Ruška, Berislav; Pavičić, Tin; Pavlović, Ivan; Junaković, Anamari; Adamec, Ivan; Crnošija, Luka; Krbot Skorić, Magdalena; Habek, Mario

Citirajte ovaj rad

Ruška, B., Pavičić, T., Pavlović, I., Junaković, A., Adamec, I., Crnošija, L. ... Habek, M. (2018). Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting. Neurological Sciences, 39. (12), 2079-2084. doi: 10.1007/s10072-018-3542-8

Ruška, Berislav, et al. "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting." Neurological Sciences, vol. 39, br. 12, 2018, str. 2079-2084. https://doi.org/10.1007/s10072-018-3542-8

Ruška, Berislav, Tin Pavičić, Ivan Pavlović, Anamari Junaković, Ivan Adamec, Luka Crnošija, Magdalena Krbot Skorić i Mario Habek. "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting." Neurological Sciences 39, br. 12 (2018): 2079-2084. https://doi.org/10.1007/s10072-018-3542-8

Ruška, B., et al. (2018) 'Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting', Neurological Sciences, 39(12), str. 2079-2084. doi: 10.1007/s10072-018-3542-8

Ruška B, Pavičić T, Pavlović I, Junaković A, Adamec I, Crnošija L, i sur.. Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting. Neurological Sciences [Internet]. 12.2018. [pristupljeno 18.10.2024.];39(12):2079-2084. doi: 10.1007/s10072-018-3542-8

B. Ruška, et al., "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting", Neurological Sciences, vol. 39, br. 12, str. 2079-2084, Prosinac 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:006068. [Citirano: 18.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:006068
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
AutorBerislav Ruška
AutorTin Pavičić
AutorIvan Pavlović
AutorAnamari Junaković
AutorIvan Adamec
AutorLuka Crnošija
AutorMagdalena Krbot Skorić
AutorMario Habek
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
The aim of this study was to investigate the performance of the Composite Autonomic System Score-31 (COMPASS-31) questionnaire in a real-life setting in consecutive patients referred to the laboratory for objective testing of the autonomic nervous system (ANS), with the hypothesis that COMPASS-31 results differ depending on medications and findings of the tilt table test results. One hundred seventy-one consecutive patients (125 females, mean age 41.5 ± 19.3) referred for testing of the ANS were enrolled. Before testing, all patients completed the recently validated Croatian version of COMPASS-31. The following data were systematically collected for all patients: age, sex, diagnoses, and medications. Results of COMPASS-31 were significantly higher in patients taking medications with a known influence on the ANS (p < 0.001). Patients with postural orthostatic tachycardia had significantly higher orthostatic intolerance and vasomotor domains of COMPASS-31 (p = 0.048 and p = 0.022, respectively). Patients with a cardiovagal score ≥ 1 had a significantly higher vasomotor domain of COMPASS-31 compared to patients with normal results of ANS tests (p = 0.030). These findings suggest the COMPASS-31 might be a valuable screening tool for autonomic dysfunctions, as it is associated with impaired ANS tests, but usage of medications that modify the ANS should always be taken into account.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaNeurological Sciences
Brojčani podacivol. 39, br. 12, str. 2079-2084
p-ISSN1590-1874
DOIhttps://doi.org/10.1007/s10072-018-3542-8
URN:NBNurn:nbn:hr:105:006068
Datum objave publikacije2018-12
URL dokumentahttp://doi.org/10.1007/s10072-018-3542-8
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:30:45